Howard McLeod, PharmD, is a recipient of a 2012 Coriell Personalized Medicine Research Award from the Coriell Institute for Medical Research. McLeod is a Fred Eshelman Distinguished Professor and director of the Institute for Pharmacogenomics and Individualized Therapy at the … Read more

Scientists at the UNC Eshelman School of Pharmacy and the UNC School of Medicine have received a $2.4 million grant to study genetic variations in people with diabetes. The goal of the study is to identify genetic variations that may … Read more

A new study from the UNC Eshelman School of Pharmacy’s Institute for Pharmacogenomics and Individualized Therapy and UNC Lineberger Comprehensive Cancer Center evaluated twenty-nine commonly used cancer chemotherapy drugs in the laboratory and found that how patients’ genes influence their … Read more

Muin J. Khoury, MD, PhD, founding director of the CDC’s Office of Public Health Genomics, is this year’s recipient of the Award for Patient Service from the Institute for Pharmacogenomics and Individualized Therapy at the University of North Carolina at … Read more

Howard McLeod, PharmD, Fred Eshelman Distinguish Professor and director of the Institute for Pharmacogenomics and Individiualized Therapy, is featured in the first television commercial produced as part of the University’s privately funded One campaign. The ad has been running at football … Read more

Roy Fagerberg, age eighty-two, of Chapel Hill, is among more than 1.5 million Americans taking the blood thinner warfarin. The typical starting dose is five milligrams a day, but he needs only three. Two milligrams in difference are important when … Read more

Medication errors kill thousands of people each year in the United States, says Michael Cohen, a pharmacist and patient safety advocate who is this year’s recipient of the UNC Institute for Pharmacogenomics and Individualized Therapy Award for Patient Service. Cohen … Read more

University of Chicago professor Mark J. Ratain, MD, is this year’s recipient of the Award for Clinical Service presented by the Institute for Pharmacogenomics and Individualized Therapy at the University of North Carolina at Chapel Hill. The award honors a … Read more

Access to essential medicines is part of the fulfillment of the right to health, says Hans Hogerzeil, PhD, a World Health Organization leader who will speak on the subject next week at the University of North Carolina at Chapel Hill. … Read more

Howard McLeod, PharmD, will receive the Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy. The award recognizes an individual who has made outstanding contributions to pharmacotherapeutics in his or her field, according to ACCP. McLeod is a … Read more